During the past decade, Salzkammergut-Klinikum Vöcklabruck conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Salzkammergut-Klinikum Vöcklabruck" #1 sponsor was "Celgene" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Medical University Innsbruck" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Salzkammergut-Klinikum Vöcklabruck" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Salzkammergut-Klinikum Vöcklabruck" are "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Atrial Fibrillation" (1 trials), "Cancer Cervix" (1 trials), "Cancer Colorectal" (1 trials) and "Cancer Head Neck" (1 trials). Many other conditions were trialed in "Salzkammergut-Klinikum Vöcklabruck" in a lesser frequency.

Most popular intervention types in "Salzkammergut-Klinikum Vöcklabruck" are "Drug" (7 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Abraxane" (1 trials), "Apalutamide 60Mg Tab" (1 trials), "Cyclophosphamide" (1 trials) and "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Salzkammergut-Klinikum Vöcklabruck" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Salzkammergut-Klinikum Vöcklabruck". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Salzkammergut-Klinikum Vöcklabruck, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Salzkammergut-Klinikum Vöcklabruck, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Salzkammergut-Klinikum Vöcklabruck has several departments that took part in Clinical trials: "A.Ö. Lhk; Ii. Medizinische Abt. Mit Schwerpunkt Gaströnter. & Onkologie" - 6 trials, "Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin" - 4 trials, "Orthopädie LKH Steyr" - 2 trials